Shopping Cart 0
Cart Subtotal
USD 0

MediPoint: Vertebroplasty Devices-Asia-Pacific Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

MediPoint: Vertebroplasty Devices-Asia-Pacific Analysis and Market Forecasts

Summary

Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia-conditions characterized by loss of bone mass and low bone mineral density-the number of diagnosed VCF cases is increasing globally as the population ages and incidences of the aforementioned conditions grow. In general, these fractures are initially treated non-surgically with pharmacological therapies, bracing, and rest. In the event that non-surgical treatment fails to relieve pain, surgical treatment can be implemented.

Vertebroplasty and kyphoplasty are minimally invasive, fluoroscopy-guided surgical techniques that utilize acrylic cement injected into the damaged vertebral body to stabilize the fracture. Kyphoplasty is an advanced version of the conventional vertebroplasty procedure, and novel approaches such as this are causing slowed growth or decline of vertebroplasty in many mature markets. However, the exceedingly cheaper vertebroplasty procedure continues to be adopted in emerging countries where cost is a significant factor.

This report focuses on the market outlook for vertebroplasty products in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future vertebroplasty market outlook in the developed and emerging markets? What trends are affecting the APAC market?

Which are the key, high growth markets that vertebroplasty manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of vertebroplasty products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for vertebroplasty?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the vertebroplasty market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the APAC vertebroplasty market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the vertebroplasty market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the vertebroplasty market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific vertebroplasty markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Table Of Content

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.2 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Vertebroplasty Market 8

3.4 Vertebroplasty Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 13

6 Market Insights 14

6.1 APAC 14

6.1.1 Australia and New Zealand 14

6.1.2 China and Taiwan 14

6.1.3 India 15

6.1.4 Japan 15

6.1.5 South Korea 15

7 Competitive Assessment 16

7.1 Overview 16

7.2 DePuy Synthes (Johnson & Johnson) 16

7.2.1 Overview 16

7.2.2 Portfolio Assessment 16

7.2.3 Competitive Positioning 17

7.3 Globus Medical 17

7.3.1 Overview 17

7.3.2 Portfolio Assessment 18

7.3.3 News and Deals Analysis 18

7.3.4 Competitive Positioning 18

7.4 Medtronic 18

7.4.1 Overview 18

7.4.2 Portfolio Assessment 19

7.4.3 Competitive Positioning 20

7.5 Stryker 20

7.5.1 Overview 20

7.5.2 Portfolio Assessment 21

7.5.3 News and Deals Analysis 21

7.5.4 Competitive Positioning 21

7.6 Other Players 22

8 Appendix 23

8.1 Bibliography 23

8.2 Abbreviations 23

8.3 Methodology 24

8.3.1 Overview 24

8.3.2 Coverage 24

8.3.3 Secondary Research 24

8.3.4 Forecasting Methodology 25

8.3.5 Primary Research Summary 26

8.4 About MediPoint 27

8.5 About GlobalData 27

8.6 Contact Us 27

8.7 Disclaimer 28


List Of Figure

List of Figures

Figure 1: Vertebroplasty Sales for APAC, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Vertebroplasty Market 6

Table 2: APAC Vertebroplasty Volume Forecast, 2014-2023 11

Table 3: APAC Vertebroplasty Average Selling Price Forecast ($), 2014-2023 12

Table 4: APAC Vertebroplasty Market Revenue Forecast ($M), 2014-2023 13

Table 5: APAC VCF Repair Company Share Analysis, 2016 13

Table 6: DePuy Synthes-Key Marketed Products Assessment 16

Table 7: Globus Medical-Key Marketed Products Assessment 18

Table 8: Medtronic-Key Marketed Products Assessment 19

Table 9: Stryker-Key Marketed Products Assessment 21

Table 10: Summary of Other Players in the Vertebroplasty Market, 2017 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

DePuy Synthes (Johnson & Johnson)

Globus Medical

Medtronic

Stryker

MediPoint: Vertebroplasty Devices-Asia-Pacific Analysis and Market Forecasts

Summary

Vertebral compression fractures (VCFs) are often characterized by pain and deformity due to the fracture and collapse of one or more vertebral bodies in the spinal column. Primarily caused by osteoporosis and osteopenia-conditions characterized by loss of bone mass and low bone mineral density-the number of diagnosed VCF cases is increasing globally as the population ages and incidences of the aforementioned conditions grow. In general, these fractures are initially treated non-surgically with pharmacological therapies, bracing, and rest. In the event that non-surgical treatment fails to relieve pain, surgical treatment can be implemented.

Vertebroplasty and kyphoplasty are minimally invasive, fluoroscopy-guided surgical techniques that utilize acrylic cement injected into the damaged vertebral body to stabilize the fracture. Kyphoplasty is an advanced version of the conventional vertebroplasty procedure, and novel approaches such as this are causing slowed growth or decline of vertebroplasty in many mature markets. However, the exceedingly cheaper vertebroplasty procedure continues to be adopted in emerging countries where cost is a significant factor.

This report focuses on the market outlook for vertebroplasty products in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future vertebroplasty market outlook in the developed and emerging markets? What trends are affecting the APAC market?

Which are the key, high growth markets that vertebroplasty manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of vertebroplasty products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for vertebroplasty?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the vertebroplasty market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the APAC vertebroplasty market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the vertebroplasty market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the vertebroplasty market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific vertebroplasty markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.2 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Vertebroplasty Market 8

3.4 Vertebroplasty Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 13

6 Market Insights 14

6.1 APAC 14

6.1.1 Australia and New Zealand 14

6.1.2 China and Taiwan 14

6.1.3 India 15

6.1.4 Japan 15

6.1.5 South Korea 15

7 Competitive Assessment 16

7.1 Overview 16

7.2 DePuy Synthes (Johnson & Johnson) 16

7.2.1 Overview 16

7.2.2 Portfolio Assessment 16

7.2.3 Competitive Positioning 17

7.3 Globus Medical 17

7.3.1 Overview 17

7.3.2 Portfolio Assessment 18

7.3.3 News and Deals Analysis 18

7.3.4 Competitive Positioning 18

7.4 Medtronic 18

7.4.1 Overview 18

7.4.2 Portfolio Assessment 19

7.4.3 Competitive Positioning 20

7.5 Stryker 20

7.5.1 Overview 20

7.5.2 Portfolio Assessment 21

7.5.3 News and Deals Analysis 21

7.5.4 Competitive Positioning 21

7.6 Other Players 22

8 Appendix 23

8.1 Bibliography 23

8.2 Abbreviations 23

8.3 Methodology 24

8.3.1 Overview 24

8.3.2 Coverage 24

8.3.3 Secondary Research 24

8.3.4 Forecasting Methodology 25

8.3.5 Primary Research Summary 26

8.4 About MediPoint 27

8.5 About GlobalData 27

8.6 Contact Us 27

8.7 Disclaimer 28


List Of Figure

List of Figures

Figure 1: Vertebroplasty Sales for APAC, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Vertebroplasty Market 6

Table 2: APAC Vertebroplasty Volume Forecast, 2014-2023 11

Table 3: APAC Vertebroplasty Average Selling Price Forecast ($), 2014-2023 12

Table 4: APAC Vertebroplasty Market Revenue Forecast ($M), 2014-2023 13

Table 5: APAC VCF Repair Company Share Analysis, 2016 13

Table 6: DePuy Synthes-Key Marketed Products Assessment 16

Table 7: Globus Medical-Key Marketed Products Assessment 18

Table 8: Medtronic-Key Marketed Products Assessment 19

Table 9: Stryker-Key Marketed Products Assessment 21

Table 10: Summary of Other Players in the Vertebroplasty Market, 2017 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

DePuy Synthes (Johnson & Johnson)

Globus Medical

Medtronic

Stryker